Maraviroc, a CCR5 antagonist, prevents the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Perez-Martinez, L. [1 ]
Perez-Matute, P. [1 ]
Aguilera-Lizarraga, J. [1 ]
Rubio, S. [2 ]
Narro, J. [3 ]
Ochoa-Callejero, L. [3 ]
Oteo, J. A. [1 ]
Blanco, J. R. [1 ]
机构：
[1] Ctr Biomed Res La Rioja CIBIR, Infect Dis Area, Logrono, Spain
[2] Hosp San Pedro, Pathol Serv, Logrono, Spain
[3] Ctr Biomed Res Rioja La CIBIR, Oncol Area, Logrono, Spain
来源：
ANTIVIRAL THERAPY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A69 / A69
页数：1
相关论文
共 50 条
  • [21] SARCOPENIA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Yerragorla, Priyanka
    Nepal, Pankaj
    Nekkalapudi, Divya
    Andreias, Laura
    Ahmed, Shady
    Dabas, Ritu
    Mousavi, Ali
    Morcos, Morcos
    Matari, Hussein
    Harley, Jennifer
    Bergasa, Nora V.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1174 - S1175
  • [22] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [23] Echocardiography and NAFLD (non-alcoholic fatty liver disease)
    Trovato, Francesca M.
    Martines, Giuseppe F.
    Catalano, Daniela
    Musumeci, Giuseppe
    Pirri, Clara
    Trovato, Guglielmo M.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 275 - 279
  • [24] Non-alcoholic fatty liver disease (NAFLD) and mortality
    Ruhl, Constance E.
    Everhart, James E.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (03) : 593 - 593
  • [25] Diagnosis of non-alcoholic fatty liver disease (NAFLD)
    Hannele Yki-Järvinen
    [J]. Diabetologia, 2016, 59 : 1104 - 1111
  • [26] Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity
    Patell, Rushad
    Dosi, Rupal
    Joshi, Harshal
    Sheth, Smit
    Shah, Purav
    Jasdanwala, Sarfaraz
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (01) : 62 - 66
  • [27] Diagnosis of non-alcoholic fatty liver disease (NAFLD)
    Yki-Jarvinen, Hannele
    [J]. DIABETOLOGIA, 2016, 59 (06) : 1104 - 1111
  • [28] Non-alcoholic fatty liver disease (NAFLD) in children
    Roberts, EA
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2306 - 2318
  • [29] Differential hepatic gene expression profiles between steatosis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Lau, DTY
    Ma, HB
    Abdo, BO
    Luxon, BA
    Sinha, M
    Beard, MR
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A672 - A672
  • [30] Lactotransferrin Prevents Hepatic Steatosis through Inhibition of Hepatic Dietary Lipid Uptake in Hormone Disturbance Non-alcoholic Fatty Liver Disease Model
    Lee, Sungmin
    Son, Beomseok
    Park, Gaeul
    Kim, Wanyeon
    Youn, HyeSook
    Youn, BuHyun
    [J]. FASEB JOURNAL, 2017, 31
12345